|  | 
| MechanismPeptidoglycan inhibitors [+1]  | 
|  | 
|  | 
|  | 
|  | 
| Drug Highest PhaseApproved | 
| First Approval Ctry. / Loc.United States | 
| First Approval Date11 Sep 2009 | 
100 Clinical Results associated with Theravance Biopharma Ireland Umited
0  Patents (Medical) associated with Theravance Biopharma Ireland Umited
100 Deals associated with Theravance Biopharma Ireland Umited
100 Translational Medicine associated with Theravance Biopharma Ireland Umited